Industry and HHS should collaborate to develop a voluntary standardized identifier for provider networks that is consistent ...

Arialys Therapeutics Receives FDA Rare Pediatric Disease Designation for ART5803 to Treat Anti-NMDA Receptor Encephalitis ...

Ukrainian President Volodymyr Zelensky and NATO Secretary General Mark Rutte discussed the effectiveness and further expansion of the PURL initiative. — Ukrinform.

Deputy Prime Minister for Restoration and Minister for Communities and Territories Development of Ukraine, Oleksii Kuleba, ...

The Pentagon said it would forbid reporters from gathering any information that had not been authorized for release, and ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

If you want to enjoy the many arts and cultural opportunities in the region for free, the Allegheny Regional Asset District ...

The Food and Drug Administration (FDA) has issued another Complete Response Letter (CRL) to Regeneron for the Biologics License Application (BLA) for odronextamab in relapsed/refractory follicular ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

Oregon health officials have turned over personally sensitive data about some Medicaid patients to the federal government as part of a spending probe — a move that follows months of heated debate over ...

Zilganersen is an antisense oligonucleotide designed to block the production of excess GFAP caused by mutations in the GFAP gene.

As we see this through Daniel’s eyes, implementation details regarding addressing often reveal fundamental design constraints ...